|
gptkbp:instance_of
|
gptkb:pharmaceuticals
|
|
gptkbp:age_group
|
adults
children over 12 years
|
|
gptkbp:approves
|
gptkb:1980s
|
|
gptkbp:available_in
|
gptkb:bottle
|
|
gptkbp:available_over_the_counter
|
gptkb:true
|
|
gptkbp:brand
|
gptkb:Gaviscon
|
|
gptkbp:clinical_trial
|
studied for efficacy
studied for safety
|
|
gptkbp:clinical_use
|
symptomatic relief
|
|
gptkbp:color
|
clear
|
|
gptkbp:contraindication
|
calcium sensitivity
sodium restriction
|
|
gptkbp:country_of_origin
|
gptkb:United_Kingdom
|
|
gptkbp:dosage_form
|
oral solution
10-20 ml
|
|
gptkbp:duration
|
up to 4 hours
|
|
gptkbp:flavor
|
gptkb:original
gptkb:mint
aniseed
|
|
gptkbp:form
|
gptkb:liquid
|
|
gptkbp:formulation
|
suspension
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Gaviscon Liquid
|
|
gptkbp:indication
|
esophagitis
gastroesophageal reflux disease (GERD)
dyspepsia
|
|
gptkbp:ingredients
|
calcium carbonate
sodium alginate
potassium bicarbonate
|
|
gptkbp:interacts_with
|
certain medications
other antacids
|
|
gptkbp:manufacturer
|
gptkb:Reckitt_Benckiser
|
|
gptkbp:mechanism_of_action
|
forms a protective barrier
|
|
gptkbp:p_hlevel
|
neutral to alkaline
|
|
gptkbp:packaging
|
liquid bottle
|
|
gptkbp:patient_population
|
adults and children
|
|
gptkbp:provides_guidance_on
|
recommended for symptomatic treatment
|
|
gptkbp:requires
|
false
|
|
gptkbp:route_of_administration
|
oral
|
|
gptkbp:service_frequency
|
as needed
|
|
gptkbp:shelf_life
|
3 years
|
|
gptkbp:side_effect
|
nausea
allergic reactions
diarrhea
constipation
stomach cramps
flatulence
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:taste
|
gptkb:sweet
|
|
gptkbp:used_for
|
acid reflux
heartburn
|
|
gptkbp:bfsParent
|
gptkb:Reckitt_Benckiser
|
|
gptkbp:bfsLayer
|
5
|